ADVANCED RENAL CELL CARCINOMA

This study is testing a new medicine called PF-08634404 for adults with advanced kidney cancer that has spread. Researchers want to see if the medicine is safe and effective when given alone or with other cancer drugs. The study is recruiting 224 adults who haven't received any t…

This early-stage trial is testing a new treatment that combines modified immune cells with chemotherapy for people with advanced kidney cancer, mesothelioma, or bone cancer. Researchers will give patients donated immune cells that have been engineered in a lab to better target an…

This early-stage trial is testing the safety of combining a wearable device that uses electric fields to disrupt cancer cells with different drug combinations. It is for adults with advanced cancers in the abdomen or chest that have spread and who have run out of standard treatme…

This study is testing whether giving standard cancer treatments at home is as safe and effective as giving them in a clinic. It aims to see if receiving care at home reduces stress, improves quality of life, and is preferred by patients with advanced cancers. About 220 participan…

This study is testing a new combination of drugs (SHR-8068 and adebrelimab) for people with advanced kidney cancer that cannot be removed by surgery. The main goals are to find a safe dose and see how well the treatment shrinks tumors. It is for adults whose cancer has spread and…

This study is for people with advanced kidney cancer that has come back after they received standard post-surgery treatment. It aims to see if a new drug called zanzalintinib, taken alone or combined with an immunotherapy drug (nivolumab), can help control the cancer. About 70 pa…

This study is testing whether giving a cancer immunotherapy treatment called nivolumab as an injection at home is a safe and practical alternative to receiving it at a clinic. It aims to see if home treatment reduces the burden of travel and improves quality of life for patients …